Hemoglobin (Hb) SD-Los Angeles compound heterozygotes usually have a severe clinical course although the effect of an elevated Hb F on the clinical phenotype has not been reported previously. We describe 5 Kuwaiti children with Hb SD associated with Hb F levels >20%. They all presented with sickling-related symptoms by ≤2 years of age and have been followed for 3–15 years. All had severe clinical courses marked by varying degrees of splenic sequestration crises, acute chest syndrome, vaso-occlusive crises, osteomyelitis and avascular necrosis of the femoral head. This pattern is in contrast with the usually mild presentation in Kuwaiti Hb SS patients with elevated Hb F. It therefore appears that Hb F does not ameliorate the clinical phenotype in Hb SD-Los Angeles. The reasons for this are not quite clear.

Keywords:
Avascular necrosis, Hb F, Hb SD-Los Angeles, Hemoglobin, Sickle cell disease, Vaso-occlusive crises
1.
Huisman THJ, Carver A, Efremov GD: A Syllabus of Hemoglobin Variants, ed 2. Augusta, Sickle Cell Anemia Foundation. 1998, p 252.
2.
Itano H: A third abnormal hemoglobin associated with hereditary hemolytic anemia. Proc Natl Acad Sci USA 1951;37:775.
3.
Hynes M, Lehman H: Haemoglobin D in a Persian girl: presumably the first case of haemoglobin-D-thalassemia. Br Med J 1956;ii: 923–924.
4.
Babin DR, Jones RT, Schroeder WA: Hemoglobin D Los Angeles:α2β2121 GluNH2. Biochim Biophys Acta 1964;86:136–143.
5.
Atalay EO, Atalay A, Ustel E, Yildiz S, Ozturk O, Koseler A, Bahadir A: Genetic origin of Hb D-Los Angeles [β121(GH4) Glu→Gln, G AA→C AA] according to the β-globin gene cluster haplotypes. Hemoglobin 2007;31:387–391.
6.
Bahadir A, Koseler A, Atalay A, Koyuncu H, Akar E, Akar N, Atalay EO: Hb D-Los Angeles [beta121(GH4)Glu>Gn] and Hb Beograd [beta121(GH4)Glu>Val]. Implications for their laboratory diagnosis and genetic origins. Turk J Hematol 2009;26:17–20.
7.
Sturgeon P, Itano HA, Bergren WR: Clinical manifestations of inherited abnormal hemoglobins. I. The interaction of Hb-S with Hb-D. Blood 1955;10:389.
8.
Schneider RG, Ueda S, Alperin JB, Levin WC, Jones RT, Brimhall B: Haemoglobin D Los Angeles in two Caucasian families: hemoglobin SD disease and hemoglobin D thalassemia. Blood 1968;32:250–259.
9.
Kelleher JF, Park JOK, Kim HC, Schroeder WA: Life-threatening complications in a child with hemoglobin SD-Los Angeles disease. Hemoglobin 1984;8:203–213.
10.
Mukherjee MB, Surve RR, Gangakhedkar RR, Mohanty D, Colah RB: Hemoglobin sickle D Punjab – a case report. Indian J Hum Genet 2005;11:154–156.
11.
Adachi K, Kim J, Ballas S, Surrey S, Asakura T: Facilitation of Hb S polymerization by the substitution of Glu for Gln at β121. J Biol Chem 1988;263:5607–5610.
12.
Powars DR: Sickle cell anaemia: βS-globin gene cluster haplotypes as prognostic indicators of vital organ damage. Semin Hematol 1991;28:202–208.
13.
Steinberg MH, Adewoye AH: Modifier genes in sickle cell disease. Curr Opin Hematol 2006;13:131–136.
14.
Adekile AD, Huisman THJ: Hb F in sickle cell anemia. Experientia 1993;49:16–27.
15.
Adekile AD, Haider MZ: Morbidity, βS haplotype and α-globin gene patterns in SS patients from Kuwait. Acta Haematol 1996;96:150–154.
16.
Adekile AD, Al-Kandari M, Haider M, Marouf R, D’Souza M, Sukumaran J: Hemoglobin F concentration as a function of age in Kuwaiti sickle cell patients. Med Princ Pract 2007;16:286–290.
17.
Adekile AD, Owunwanne A, Al-Za’abi K, Haider MZ, Tuli M, Al-Mohannadi S: Temporal sequence of splenic dysfunction in sickle cell disease. Am J Hematol 2002;69:23–27.
18.
Adekile AD, Gupta R, Yacoub F, Sinan T, Al-Bloushi M, Haider MZ: Avascular necrosis of the hip in Kuwaiti children with sickle cell disease: MRI images and association with α-thalassaemia trait. Acta Haematol 2001;105:27–31.
19.
Adekile AD, Yacoub F, Gupta R, Sinan T, Al-Bloushi M, Haider MZ, Habib Y, Moosa A: Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and elevated Hb F. Am J Hematol 2002;70:228–231.
20.
Bissé E, Wieland H: High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins. J. Chromatogr 1988;434:95–110.
21.
Lanclos KD, Oner C, Dimovski AJ, Gu Y-C, Huisman THJ: Sequence variations in the 5′ flanking and IVS-II regions of the Gγ- and Aγ-globin genes of the βS chromosomes with five different haplotypes. Blood 1991;77:2488–2496.
22.
Charache S, Conley CL: Rate of sickling of red cells during deoxygenation of blood from persons with various sickling disorders. Blood 1964;24:25–48.
23.
Milner PF, Miller C, Grey R, Seakins M, DeJong WW, Went LN: Hemoglobin O Arab in four Negro families and its interaction with hemoglobin S and hemoglobin C. N Engl J Med 1970;283:1413–1425.
24.
Charache S, Zinkham WH, Dickerman JD, Brimhall B, Dover GJ: Hemoglobin SC, SS/GPhiladelphia, and SO-Arab diseases: diagnostic importance of an integrative analysis of clinical, hematologic and electrophoretic findings. Am J Med 1977;62:439–445.
25.
Bookchin RM, Nagel RL, Balazs T: Role of hybrid tetramer formation in gelation of hemoglobin S. Nature 1975;256:667–668.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.